Cargando…

Genetic variation and cognitive dysfunction in opioid‐treated patients with cancer

BACKGROUND AND PURPOSE: The effects of single‐nucleotide polymorphisms (SNPs) on the cognitive function of opioid‐treated patients with cancer until now have not been explored, but they could potentially be related to poor functioning. This study aimed at identifying associations between SNPs of can...

Descripción completa

Detalles Bibliográficos
Autores principales:	Kurita, Geana Paula, Ekholm, Ola, Kaasa, Stein, Klepstad, Pål, Skorpen, Frank, Sjøgren, Per
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	John Wiley and Sons Inc. 2016
Materias:	Original Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4864175/ https://www.ncbi.nlm.nih.gov/pubmed/27247849 http://dx.doi.org/10.1002/brb3.471

Ejemplares similares

Genetic and Non-genetic Factors Associated With Constipation in Cancer Patients Receiving Opioids
por: Laugsand, Eivor A, et al.
Publicado: (2015)

Interventional Techniques for the Management of Cancer-Related Pain: Clinical and Critical Aspects
por: Kurita, Geana Paula, et al.
Publicado: (2019)

Innate Immune Signalling Genetics of Pain, Cognitive Dysfunction and Sickness Symptoms in Cancer Pain Patients Treated with Transdermal Fentanyl
por: Barratt, Daniel T., et al.
Publicado: (2015)

Genetic variation in the Catechol-O-Methyltransferase (COMT) gene and morphine requirements in cancer patients with pain
por: Rakvåg, Trude T, et al.
Publicado: (2008)

Identification of genetic polymorphisms modulating nausea and vomiting in two series of opioid-treated cancer patients
por: Colombo, Francesca, et al.
Publicado: (2020)

Health care providers underestimate symptom intensities of cancer patients: A multicenter European study
por: Laugsand, Eivor A, et al.
Publicado: (2010)

Can variability in the effect of opioids on refractory breathlessness be explained by genetic factors?
por: Currow, David C, et al.
Publicado: (2015)

Is there a genetic cause of appetite loss?—an explorative study in 1,853 cancer patients
por: Solheim, Tora S., et al.
Publicado: (2012)

Prediction of opioid dose in cancer pain patients using genetic profiling: not yet an option with support vector machine learning
por: Olesen, Anne Estrup, et al.
Publicado: (2018)

Day-to-day variations during clinical drug monitoring of morphine, morphine-3-glucuronide and morphine-6-glucuronide serum concentrations in cancer patients. A prospective observational study
por: Klepstad, Pål, et al.
Publicado: (2004)

Do CYP2D6 genotypes reflect oxycodone requirements for cancer patients treated for cancer pain? A cross-sectional multicentre study
por: Andreassen, Trine Naalsund, et al.
Publicado: (2011)

Can cancer patients assess the influence of pain on functions? A randomised, controlled study of the pain interference items in the Brief Pain Inventory
por: Stenseth, Guri, et al.
Publicado: (2007)

Development of a systematic multidisciplinary clinical and teaching model for the palliative approaches in patients with severe lung failure
por: Marsaa, Kristoffer, et al.
Publicado: (2022)

Is there a genetic cause for cancer cachexia? – a clinical validation study in 1797 patients
por: Solheim, T S, et al.
Publicado: (2011)

Inadequate symptom control in advanced cancer patients across Europe
por: Laugsand, Eivor A., et al.
Publicado: (2010)

Influences on the pharmacokinetics of oxycodone: a multicentre cross-sectional study in 439 adult cancer patients
por: Andreassen, Trine Naalsund, et al.
Publicado: (2010)

Zopiclone versus placebo for short-term treatment of insomnia in patients with advanced cancer—a double-blind, randomized placebo-controlled clinical multicenter phase IV trial
por: Jakobsen, Gunnhild, et al.
Publicado: (2022)

The relationship between pro-inflammatory cytokines and pain, appetite and fatigue in patients with advanced cancer
por: Paulsen, Ørnulf, et al.
Publicado: (2017)

Pain Intensity Factors Changing Breakthrough Pain Prevalence in Patients with Advanced Cancer: A Secondary Analysis of a Cross-Sectional Observational International Study
por: Løhre, Erik Torbjørn, et al.
Publicado: (2018)

Cohort Description: Preventing an Opioid Epidemic in Norway – Focusing on Treatment of Chronic Pain (POINT) – A National Registry-Based Study
por: Hamina, Aleksi, et al.
Publicado: (2022)

An exploratory study examining the relationship between performance status and systemic inflammation frameworks and cytokine profiles in patients with advanced cancer
por: Dolan, Ross D., et al.
Publicado: (2019)

Benefits of Study Participation for Patients with Advanced Cancer Receiving Radiotherapy: A Prospective Observational Study
por: Bye, Asta, et al.
Publicado: (2022)

Clinically significant drug–drug interactions involving opioid analgesics used for pain treatment in patients with cancer: a systematic review
por: Kotlinska-Lemieszek, Aleksandra, et al.
Publicado: (2015)

Longitudinal Associations between Exercise and Pain in the General Population - The HUNT Pain Study
por: Landmark, Tormod, et al.
Publicado: (2013)

Zopiclone versus placebo for short-term treatment of insomnia in patients with advanced cancer: study protocol for a double-blind, randomized, placebo-controlled, clinical multicenter trial
por: Jakobsen, Gunnhild, et al.
Publicado: (2018)

The short-term impact of methylprednisolone on patient-reported sleep in patients with advanced cancer in a randomized, placebo-controlled, double-blind trial
por: Jakobsen, Gunnhild, et al.
Publicado: (2020)

The DOMUS study protocol: a randomized clinical trial of accelerated transition from oncological treatment to specialized palliative care at home
por: Nordly, Mie, et al.
Publicado: (2014)

Effectiveness of Opioid Switching in Advanced Cancer Pain: A Prospective Observational Cohort Study
por: Wong, Aaron K., et al.
Publicado: (2023)

Continuous subcutaneous infusion for pain control in dying patients: experiences from a tertiary palliative care center
por: Fürst, Per, et al.
Publicado: (2020)

The N-Terminally Truncated µ3 and µ3-Like Opioid Receptors Are Transcribed from a Novel Promoter Upstream of Exon 2 in the Human OPRM1 Gene
por: Andersen, Sonja, et al.
Publicado: (2013)

Power Comparisons and Clinical Meaning of Outcome Measures in Assessing Treatment Effect in Cancer Cachexia: Secondary Analysis From a Randomized Pilot Multimodal Intervention Trial
por: Balstad, Trude R., et al.
Publicado: (2021)

Genetic variation regulates opioid-induced respiratory depression in mice
por: Bubier, Jason A., et al.
Publicado: (2020)

Use of National Early Warning Score for observation for increased risk for clinical deterioration during post-ICU care at a surgical ward
por: Klepstad, Pia Katrin, et al.
Publicado: (2019)

Genetic Variation for Cardiac Dysfunction in Drosophila
por: Ocorr, Karen A., et al.
Publicado: (2007)

Cancer patients’ knowledge about their disease and treatment before, during and after treatment: a prospective, longitudinal study
por: Berger, Ola, et al.
Publicado: (2018)

Adapting behavioural interventions to compensate for cognitive dysfunction in persons with opioid use disorder
por: Mistler, Colleen B, et al.
Publicado: (2021)

Touch-induced face conditioning is mediated by genetic variation in opioid but not oxytocin receptors
por: Fu, Yu, et al.
Publicado: (2018)

Genetic Heterogeneity in Latent Autoimmune Diabetes Is Linked to Various Degrees of Autoimmune Activity: Results From the Nord-Trøndelag Health Study
por: Pettersen, Elin, et al.
Publicado: (2010)

Comparison of the Impacts of Under-Treated Pain and Opioid Pain Medication on Cognitive Impairment
por: Jang, Sung Eun, et al.
Publicado: (2022)

Short-term effects of continuous cover forestry on forest biomass production and biodiversity: Applying single-tree selection in forests dominated by Picea abies
por: Ekholm, Adam, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_ilu8suijknmno5tf2if3h8gc37